Barclays
AGN

Barclays’s Allergan plc AGN Stock Holding History

Barclays’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,151,403
Closed -$735M – 6564
2020
Q1 		$735M Buy
4,151,403
+150,948
+4% +$28.4M 0.58% 26
2019
Q4 		$765M Buy
4,000,455
+513,002
+15% +$92.5M 0.42% 34
2019
Q3 		$587M Buy
3,487,453
+2,840,168
+439% +$463M 0.37% 36
2019
Q2 		$108M Buy
647,285
+90,422
+16% +$12.5M 0.07% 245
2019
Q1 		$81.5M Sell
556,863
-457,203
-45% -$66.3M 0.06% 298
2018
Q4 		$136M Buy
1,014,066
+249,359
+33% +$40.9M 0.1% 138
2018
Q3 		$146M Buy
764,707
+32,256
+4% +$5.93M 0.1% 149
2018
Q2 		$122M Sell
732,451
-75,871
-9% -$12.2M 0.1% 155
2018
Q1 		$136M Buy
808,322
+182,733
+29% +$30.7M 0.1% 163
2017
Q4 		$102M Buy
625,589
+183,771
+42% +$33M 0.08% 197
2017
Q3 		$90.5M Buy
441,818
+171,149
+63% +$39.8M 0.09% 172
2017
Q2 		$65.8M Sell
270,669
-179,073
-40% -$42.1M 0.07% 217
2017
Q1 		$107M Buy
449,742
+162,637
+57% +$37.9M 0.12% 128
2016
Q4 		$60.3M Sell
287,105
-78,794
-22% -$16.3M 0.07% 234
2016
Q3 		$84.3M Buy
365,899
+96,369
+36% +$23.5M 0.09% 163
2016
Q2 		$62.3M Sell
269,530
-136,359
-34% -$31.4M 0.08% 209
2016
Q1 		$109M Buy
405,889
+76,108
+23% +$21.8M 0.17% 104
2015
Q4 		$103M Buy
329,781
+126,481
+62% +$37.7M 0.12% 143
2015
Q3 		$55.1M Sell
203,300
-56,146
-22% -$17.2M 0.07% 253
2015
Q2 		$78.6M Sell
259,446
-98,823
-28% -$29.5M 0.09% 190
2015
Q1 		$106M Sell
358,269
-184,847
-34% -$52.7M 0.12% 146
2014
Q4 		$140M Sell
543,116
-175,813
-24% -$43.9M 0.13% 116
2014
Q3 		$173M Buy
718,929
+577,836
+410% +$129M 0.17% 83
2014
Q2 		$31.5M Sell
141,093
-59,532
-30% -$12.3M 0.03% 473
2014
Q1 		$41.1M Sell
200,625
-414,740
-67% -$82.2M 0.05% 357
2013
Q4 		$103M Buy
615,365
+460,753
+298% +$72M 0.11% 153
2013
Q3 		$22.3M Buy
154,612
+32,673
+27% +$4.35M 0.03% 611
2013
Q2 		$15.4M Buy
+121,939
New +$13.8M 0.02% 786

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Barclays's AGN Position: Q2 2020 in Review

Barclays sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,151,403 shares — an estimated $735M sold.

Barclays first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $765M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Barclays reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Barclays sold 4,151,403 Allergan plc shares in Q2 2020, an estimated $735M.
  • Barclays first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Barclays's Allergan plc position peaked at $765M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.